The utilisation of nuchal translucency as a prenatal marker of Down syndrome, 1993-1999

Aust N Z J Obstet Gynaecol. 2000 Nov;40(4):423-6. doi: 10.1111/j.1479-828x.2000.tb01173.x.

Abstract

A sample of 6,038 obstetric ultrasound referrals and reports between January 1993 and June 1999 in a single Melbourne private ultrasound practice was reviewed to determine whether the referral and reporting pattern for nuchal translucency (NT) measurement has changed. The proportion of both 10-14 week ultrasound scans and mid trimester fetal anatomy scan referrals increased significantly over the study period (p < 0.001 and p < 0.001, respectively). There was also a significant increase in NT reporting and the number of specific referrals for an NT measurement over the study period (p = 0.01 and p < 0.001, respectively). If current trends continue it is likely that the 10-14 week scan for NT measurement will become a routine component of antenatal care. Therefore, as a matter of urgency, it is imperative that the best and most cost-effective screening strategy for Down syndrome in an Australian population is defined.

MeSH terms

  • Biomarkers*
  • Cost-Benefit Analysis
  • Down Syndrome / diagnostic imaging*
  • Female
  • Health Care Surveys
  • Humans
  • Mass Screening / methods*
  • Neck / diagnostic imaging*
  • Needs Assessment
  • Practice Patterns, Physicians' / economics
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Pregnancy
  • Pregnancy Trimester, First
  • Private Practice / economics
  • Private Practice / statistics & numerical data*
  • Referral and Consultation / economics
  • Referral and Consultation / statistics & numerical data*
  • Reproducibility of Results
  • Ultrasonography, Prenatal / economics
  • Ultrasonography, Prenatal / statistics & numerical data*
  • Ultrasonography, Prenatal / trends*
  • Victoria

Substances

  • Biomarkers